Indo Borax & Chemicals Ltd Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 25 Aug 2026 | Chemicals & Petrochemicals | Market Cap: ₹1.4K Cr
The company achieved Rs. The company showed revenue growth from Rs.175 crores to Rs.215 crores between recent financial years, expecting 20%-35% revenue growth going forward, driven by increased realization, higher volumes through debottlenecking, operational efficiency, and new products. - EBITDA margins are targeted to be maintained or improved; current EBITDA margins are around 20%-21%. - Net profit (PAT) increased 41.9% to Rs.14.53 crores in Q4 FY26; annual PAT was Rs.50.27 crores versus Rs.42.51 crores prior year. - EPS stood at Rs.4.53 for Q4 FY26 and Rs.15.67 for FY26. - Management expects sales to reach Rs.250+ crores next year, with sustained or improved earnings quality. - Focus on sustainable long-term growth through capacity expansion, new product lines (Boron Oxide, Boric Acid I.P.
From Indo Borax & Chemicals Ltd's Q4 FY26 earnings-call transcript · updated 25 Aug 2026.
Price
₹488
Market Cap
₹1.4K Cr
P/E Ratio
27.9
Revenue Rank
Margin Rank
How does Indo Borax & Chemicals Ltd rank in Chemicals & Petrochemicals?
Compare Indo Borax & Chemicals Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.
Indo Borax & Chemicals Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹63 Cr, net profit ₹15 Cr.
Full financials →📊 Revenue & Sales Performance
Rank 2- →The company achieved Rs. 175 crores revenue in the previous financial year and Rs. 215 crores in FY26, showing strong growth.
- →Management expects revenue growth between 20% to 35% in the coming years, driven by increased realisation, higher volumes from debottlenecking, operational efficiency, and new products.
- →Full capacity utilisation may boost revenue by 25% to 30% without additional CAPEX within one to one and a half years.
- →Sales volume growth and better price realisations are expected, especially in Boric Acid and DOT products.
- →Plans for expanding into new product lines, such as Boron Oxide, are underway to tap further growth opportunities.
- →Boric Acid volumes have grown from 600 tons to about 980 tons recently, with a target to reach 1,500 tons next year.
- →Exploration into new-age applications and export markets is ongoing, expected to materialise in the coming quarters.
📈 Profitability & Margins
Rank 3- →The company showed revenue growth from Rs.175 crores to Rs.215 crores between recent financial years, expecting 20%-35% revenue growth going forward, driven by increased realization, higher volumes through debottlenecking, operational efficiency, and new products.
- →EBITDA margins are targeted to be maintained or improved; current EBITDA margins are around 20%-21%.
- →Net profit (PAT) increased 41.9% to Rs.14.53 crores in Q4 FY26; annual PAT was Rs.50.27 crores versus Rs.42.51 crores prior year.
- →EPS stood at Rs.4.53 for Q4 FY26 and Rs.15.67 for FY26.
- →Management expects sales to reach Rs.250+ crores next year, with sustained or improved earnings quality.
- →Focus on sustainable long-term growth through capacity expansion, new product lines (Boron Oxide, Boric Acid I.P. Grade, DOT), and exploration of new market segments.
- →Continued transparent updates and investor engagement committed by management.
🏗️ Capital Expenditure Plans
Yes- →The company is actively pushing ahead with CAPEX plans to expand capacity and broaden the product portfolio; details will be shared post board approval as discussions are ongoing (Page 4).
- →Sufficient cash is available for budgeted CAPEX over the next two years while maintaining a strong balance sheet with zero debt (Page 12).
- →The management is monetizing non-core assets to fund future technologies and investments (Page 12).
- →There are strategic discussions about potential acquisitions or further investments, supported by Zenrock Chemicals' experience and cash availability (Page 11-12).
- →Debottlenecking and operational efficiency improvements are planned to increase volumes without major CAPEX in the near term (Page 25).
- →Exploration of new product lines and forward integration opportunities within boron chemistry is underway, aiming at growth through both domestic and export markets (Pages 4, 15, 27).
- →The leadership is focused on sustainable long-term growth with transparent investor communication (Page 28).
💰 Fundraising & Capital Structure
No information- →No explicit mention of new fundraising through debt or equity in the provided text.
- →The company currently has zero debt (Page 21).
- →They have sufficient cash for planned CAPEX and growth (Page 12, 13).
- →Cash from matured fixed deposits is being reinvested into liquid mutual funds to maintain liquidity for CAPEX and opportunities (Page 22).
- →Discussions around capacity expansion and potential acquisitions indicate use of internal cash flows rather than new debt or equity (Page 12, 16).
- →No stated plans or guidance about issuing new equity or taking fresh debt during the current reporting period (Page 12, 13, 21).
- →Focus remains on sustainable growth, operational efficiency, and expanding product lines using existing resources.
📋 Order Book & Pipeline
No informationKey Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Indo Borax & Chemicals Ltd Q4 FY26 results?
The company achieved Rs. The company showed revenue growth from Rs.175 crores to Rs.215 crores between recent financial years, expecting 20%-35% revenue growth going forward, driven by increased realization, higher volumes through debottlenecking, operational efficiency, and new products. - EBITDA margins are targeted to be maintained or improved; current EBITDA margins are around 20%-21%. - Net profit (PAT) increased 41.9% to Rs.14.53 crores in Q4 FY26; annual PAT was Rs.50.27 crores versus Rs.42.51 crores prior year. - EPS stood at Rs.4.53 for Q4 FY26 and Rs.15.67 for FY26. - Management expects sales to reach Rs.250+ crores next year, with sustained or improved earnings quality. - Focus on sustainable long-term growth through capacity expansion, new product lines (Boron Oxide, Boric Acid I.P.
What is Indo Borax & Chemicals Ltd share price analysis?
Indo Borax & Chemicals Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 27.9 with a market cap of ₹1,365 Cr. Investors should review the full earnings analysis for detailed insights.
Is Indo Borax & Chemicals Ltd planning capital expenditure?
The company is actively pushing ahead with CAPEX plans to expand capacity and broaden the product portfolio; details will be shared post board approval as discussions are ongoing (Page 4).
Keep Indo Borax & Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.